Fedratinib
Showing 1 - 22 of 22
Real World Evidence of Fedratinib Effectiveness in MF
Not yet recruiting
- Primary Myelofibrosis
- +2 more
- Fedratinib
- (no location specified)
May 22, 2023
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
- Fedratinib
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Assess Real-World Patient-Reported Outcomes With Fedratinib for
Recruiting
- Myelofibrosis
-
City, State, AustriaLocal Institution
Dec 16, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Fedratinib Oral Capsule [Inrebic]
- Nivolumab
-
Greifswald, Germany
- +1 more
Jun 15, 2022
Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Fedratinib Pill
-
Tampa, FloridaMoffitt Cancer Center
Jun 15, 2022
IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)
Recruiting
- IDH Mutation
- +4 more
- Ivosidenib
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022
Primary Myelofibrosis Trial in Japan (Fedratinib)
Recruiting
- Primary Myelofibrosis
- Fedratinib
-
Suwa, Nagano, Japan
- +25 more
Jan 18, 2023
Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)
Active, not recruiting
- Myelofibrosis
- +2 more
-
New Orleans, Louisiana
- +20 more
Aug 25, 2022
Myelofibrosis Trial in Summit (Oral Fedratinib)
Available
- Myelofibrosis
- Oral Fedratinib
-
Summit, New JerseyCelgene
Sep 17, 2020
Healthy Volunteers Trial in Dallas (Fedratinib, Rifampin, Efavirenz)
Completed
- Healthy Volunteers
- Fedratinib
- +2 more
-
Dallas, TexasCovance Clinical Research Unit Inc - Dallas
Aug 19, 2020
Healthy Volunteers Trial in Austin (Fedratinib, Digoxin, Rosuvastatin)
Completed
- Healthy Volunteers
- Fedratinib
- +3 more
-
Austin, TexasPPD Phase 1 Clinic
May 20, 2020
Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)
Recruiting
- Myelofibrosis
- Selinexor
- Physician's Choice Treatment
-
Los Angeles, California
- +41 more
Jan 30, 2023
Myelofibrosis Trial in Houston (CK0804)
Not yet recruiting
- Myelofibrosis
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jun 28, 2022
COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )
Terminated
- COVID
- +2 more
- Convalescent anti-SARS-CoV-2 plasma
- Infusion placebo
-
Aalborg, Denmark
- +11 more
Aug 2, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)
Recruiting
- Myeloproliferative Neoplasm (MPN)
- Myelofibrosis,MF
- flonoltinib 25mg
- +5 more
-
Chengdu, Sichuan, ChinaWest China Hospital Sichuan University
Mar 9, 2022
Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)
Not yet recruiting
- Myeloproliferative Neoplasm (MPN)
- Myelofibrosis,MF
- flonoltinib 25mg
- +5 more
- (no location specified)
Nov 2, 2021